CompoAtlas

Ching Po Ching, Lion's Mane (Capsule)

Natural health product licensed in Canada

Other names
Louie Ming Chun Ching Po Ching, Lion's Mane (Capsule)
Licence holder
Western Phytoceutica Inc
NPN or DIN-HM
80150959
Status
Active licence
Licence date
10 September 2026
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Rehmannia glutinosa

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 180 mg

60 mgNot calculated
Lycium barbarum

Source : Lycium barbarum - Fruit

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 30 mg

10 mgNot calculated
Paeonia lactiflora

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 120 mg

40 mgNot calculated
Cistanche tubulosa

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 45 mg

15 mgNot calculated
Cnidium monnieri

Source : Cnidium monnieri - Fruit

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 15 mg

5 mgNot calculated
Angelica sinensis

Source : Angelica sinensis - Racine

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 75 mg

25 mgNot calculated
Panax quinquefolius

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 250 mg

50 mgNot calculated
Hericium erinaceus

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,000 mg

Potency : 18 Pour cent beta-Glucan

100 mgNot calculated
Magnolia officinalis

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 22.5 mg

7.5 mgNot calculated
Cynomorium songaricum

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 22.5 mg

7.5 mgNot calculated
Epimedium sagittatum

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 45 mg

15 mgNot calculated
Astragalus membranaceus

Source : Astragalus membranaceus - racine

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 30 mg

10 mgNot calculated
Codonopsis pilosula

Source : Codonopsis pilosula - racine

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 75 mg

25 mgNot calculated
Morinda officinalis

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 30 mg

10 mgNot calculated
Reynoutria multiflora

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 75 mg

25 mgNot calculated
Atractylodes macrocephala

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 22.5 mg

7.5 mgNot calculated
Polygonatum odoratum

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 22.5 mg

7.5 mgNot calculated
Dioscorea oppositifolia

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 120 mg

40 mgNot calculated
Allium tuberosum

Extract : Matériel brut sec

Extraction ratio : 1.5:1

Dry plant equivalent : 22.5 mg

15 mgNot calculated
Cuscuta chinensis

Source : Cuscuta Chinensis - Graine

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 60 mg

20 mgNot calculated
Trigonella foenum-graecum

Source : Trigonella foenum-graecum - Graine

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 15 mg

5 mgNot calculated

Non-medicinal ingredients

Poudre d'enveloppes d'Oryza sativa (Riz), Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years3 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of fungal polysaccharides with immunomodulating properties. Used in Herbal Medicine as supportive therapy for the promotion of healthy (blood) glucose/sugar levels.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80150959

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Angelica sinensis
    Read the warning, when it applies and the studies cited

    DONG QUAI - ANGELICA SINENSIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid exposure to the sun (NS 2021; Thorne 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (NS 2021; WHO 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

  • Panax quinquefolius
    Read the warning, when it applies and the studies cited

    PANAX QUINQUEFOLIUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except Glucose levels and Adaptogen - immune system.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 May 2025

  • Trigonella foenum-graecum
    Read the warning, when it applies and the studies cited

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010; Mills et al. 2006; Hoffman 2003; Blumenthal et al. 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line